Effect of intrathecal fentanyl on the incidence and/or severity of postdural puncture headache in obstetric patients
Not Applicable
Completed
- Conditions
- Fertility-femaleAnaesthesia
- Registration Number
- PACTR201603001498189
- Lead Sponsor
- Maternity Hospital Minia University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 300
Inclusion Criteria
1-aged between 18- 30 years, 2- non-obese (BMI ¿ 30) , 3-belonging to ASA grade I or II and undergoing elective or emergency CS under SAB will be enrolled into the study.
Exclusion Criteria
1-contraindications to regional anesthesia, 2-history of migraine, 3-chronic headache, 4- psychiatric illness or neurological dysfunction; and5- patients requiring more than three attempts for lumbar puncture.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie intrathecal fentanyl's effect on postdural puncture headache in obstetric patients?
How does intrathecal fentanyl compare to standard-of-care treatments for preventing postdural puncture headache in women undergoing spinal anesthesia?
Are there specific biomarkers that predict the efficacy of intrathecal fentanyl in reducing postdural puncture headache severity in pregnant individuals?
What are the known adverse events associated with intrathecal fentanyl administration in obstetric patients and how are they managed?
What alternative analgesic agents or combination therapies are being explored for postdural puncture headache prevention in the context of intrathecal fentanyl research?